Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ioana-Miruna Stanciu
Observed names:
Ioana M Stanciu,
Ioana Miruna Stanciu
Institutions:
Carol Davila University of Medicine and Pharmacy,
Spitalul Universitar de Urgență Elias
Observed institutions:
Carol Davila University of Medicine and Pharmacy,
Spitalului Clinic de Urgență pentru Copii Maria Sklodowska Curie,
Spitalul Universitar de Urgență Elias,
Institutul Clinic Fundeni
ORCID:
0009-0003-5937-0778
Observed ORCID:
0009-0003-5937-0778
OpenAlex ID:
A5024278835
Mechanisms of Resistance to CDK4/6 Inhibitors and Predictive Biomarkers of Response in HR+/HER2-Metastatic Breast Cancer—A Review of the Literature
2023
·
Ioana-Miruna Stanciu
, Andreea Ioana Parosanu
, et al.
·
Diagnostics
·
51
PDF
An Overview of the Safety Profile and Clinical Impact of CDK4/6 Inhibitors in Breast Cancer—A Systematic Review of Randomized Phase II and III Clinical Trials
2023
·
Ioana-Miruna Stanciu
, Andreea Ioana Parosanu
, et al.
·
Biomolecules
·
48
PDF
The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Patients with Metastatic Renal Cell Carcinoma
2023
·
Andreea Ioana Parosanu
, Cristina Florina Pirlog
, et al.
·
Current Oncology
·
19
PDF
Metastatic Kidney Cancer: Does the Location of the Metastases Matter? Moving towards Personalized Therapy for Metastatic Renal Cell Carcinoma
2024
·
Catalin Baston
, Andreea Ioana Parosanu
, et al.
·
Biomedicines
·
15
Tumor-to-Tumor Metastasis of Lung Cancer to Kidney Cancer: A Review of the Literature and Our Experience
2024
·
Catalin Baston
, Andreea Ioana Parosanu
, et al.
·
Diagnostics
·
13
PDF
Second-Line Treatment of Metastatic Renal Cell Carcinoma in the Era of Predictive Biomarkers
2023
·
Andreea Ioana Parosanu
, Catalin Baston
, et al.
·
Diagnostics
·
10
PDF
Does the Rechallenge with Another CDK 4/6 Inhibitor in Breast Cancer Work? A Case Report and Literature Review
2023
·
Ioana-Miruna Stanciu
, Cristina Florina Pirlog
, et al.
·
Medicina
·
9
PDF
Impact of Patient Profile on CDK4/6 Inhibitor Therapy Outcomes: A Real-World Data Analysis
2025
·
Ioana-Miruna Stanciu
, Maria-Cristina Orlov-Slavu
, et al.
·
International Journal of Molecular Sciences
·
5
PDF
Early-Stage Renal Cell Carcinoma: Who Needs Adjuvant Therapy?
2025
·
Andreea Ioana Parosanu
, Cornelia Nititpir
, et al.
·
Biomedicines
·
4
PDF
Role of Tumor Molecular Profiling With FoundationOne®CDx in Advanced Solid Tumors: A Single-Centre Experience From Romania
2023
·
Ana Maria Popa
, Mihaela Andreea Stejeroiu
, et al.
·
Cureus
·
3
PDF
Real-World Quality-of-Life Data in Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors Using Four Assessment Tools
2025
·
Ioana-Miruna Stanciu
, Cornelia Nitipir
·
Cancers
·
2
Use of Immune Checkpoint Inhibitors in Elderly Patients With Chronic Kidney Disease and Renal Cell Carcinoma Metastasis of the Parotid Gland: Case Report and Review of the Literature
2022
·
Andreea Parosanu
, Cristina Orlov Slavu
, et al.
·
Cureus
·
2
PDF
Correction: Role of Tumor Molecular Profiling With FoundationOne®CDx in Advanced Solid Tumors: A Single-Centre Experience From Romania
2025
·
Ana Maria Popa
, Mihaela Andreea Stejeroiu
, et al.
·
Cureus
·
1
The Coincidence of Aspergillus and Primary Lung Adenocarcinoma. A Case Report and Literature Review
2023
·
Miruna-Ioana Lazăr
, Ioana-Miruna Stanciu
, et al.
·
Journal of Medical and Radiation Oncology
PDF
Prognostic Models for Renal Cell Carcinoma in the Era of Immune Checkpoint Therapy
2022
·
Andreea Parosanu
, Ioana Miruna Stanciu
, et al.
·
Cureus
PDF
Show more works
View as search
Works count:
15
Citation count:
182
H-index:
7
I10-index:
6
Year
Topic
Type